Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer

NCT03219476 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Invasive Breast Cancer

Interventions

DRUG: Anastrozole
DRUG: Letrozole
DRUG: Exemestane
DRUG: Tamoxifen

Sponsor

Medical College of Wisconsin